Discovery lights path for Alzheimer’s research
Researchers identify binding site on the amyloid beta peptide that could facilitate better drugs to treat the disease...
List view / Grid view
Researchers identify binding site on the amyloid beta peptide that could facilitate better drugs to treat the disease...
Researchers have performed meta-analysis of neurological and neurodegenerative diseases and created an atlas of how cell characteristics are linked to their genotype...
Micron-level, 3-D visualisation of protein deposits found in Alzheimer's disease could speed development of new treatments...
Scientists have identified that a mutation in the gene TREM2, can substantially raise a person’s risk of Alzheimer’s disease...
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
Researchers have discovered that impairing a critical partnership between brain cells can lead to neurodegeneration...
Researchers have identified that the presence of ApoE4 exacerbates the brain damage caused by toxic tangles of tau protein...
Researchers have displayed structural details of amyloid structures which may answer many questions on the growth of harmful deposits...
Alzheimer’s disease (AD) is the most prevalent form of dementia.1 The common (>95% of cases) slow-developing form of the ailment is known as late-onset AD (LOAD) or sporadic AD (SAD). The rare (
Researchers have identified a promising new avenue to explore in the search for stroke treatments...
Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...
Researchers have revealed the molecular mechanism behind a rare mutation has been associated with numerous neurodegenerative diseases...
Antibody targets thought to cause the most damage in neurological disorders, creates potential for a unified treatment approach...
Scientists have used artificial intelligence techniques and big data to develop an algorithm capable of recognising the signatures of dementia two years before its onset, using a single amyloid PET scan...
A collaboration between Prof Lucía Chávez-Gutiérrez and Prof Bart De Strooper of VIB-KU Leuven has revealed the molecular basis of the hereditary form of Alzheimer’s disease that strikes early in life.